Share on StockTwits

OraSure Technologies Inc. (NASDAQ:OSUR) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of ($0.09)-(0.08) for the period, compared to the Thomson Reuters consensus estimate of ($0.09), StockRatingsNetwork reports. The company issued revenue guidance of $26.0-26.5 million, compared to the consensus revenue estimate of $25.37 million.

Shares of OraSure Technologies Inc. (NASDAQ:OSUR) opened at 7.23 on Wednesday. OraSure Technologies Inc. has a 1-year low of $3.75 and a 1-year high of $8.60. The stock’s 50-day moving average is $6.42 and its 200-day moving average is $6.66. The company’s market cap is $403.7 million.

OraSure Technologies (NASDAQ:OSUR) last posted its quarterly earnings results on Wednesday, May 7th. The company reported ($0.10) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.13) by $0.03. The company had revenue of $23.50 million for the quarter, compared to the consensus estimate of $23.28 million. During the same quarter in the previous year, the company posted ($0.18) earnings per share. The company’s revenue for the quarter was up 10.8% on a year-over-year basis. On average, analysts predict that OraSure Technologies Inc. will post $-0.25 earnings per share for the current fiscal year.

OSUR has been the subject of a number of recent research reports. Analysts at Raymond James reiterated an outperform rating on shares of OraSure Technologies in a research note on Thursday, May 8th. They now have a $8.50 price target on the stock, down previously from $10.00. On a related note, analysts at Cowen and Company raised their price target on shares of OraSure Technologies from $8.00 to $9.00 in a research note on Friday, May 2nd. Finally, analysts at TheStreet upgraded shares of OraSure Technologies from a sell rating to a hold rating in a research note on Monday, March 17th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. OraSure Technologies currently has a consensus rating of Hold and a consensus price target of $8.03.

OraSure Technologies, Inc, is engaged in development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using the Company’s oral fluid technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.